Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...
Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains unchanged” Ricardo Rubio/Europa Press via Getty Health officials in ...